Cargando…
Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis
[Image: see text] Multidrug membrane transporters can extrude a wide range of substrates, which cause multidrug resistance and ineffective treatment of diseases. In this study, we used three different sized antibiotic drug nanocarriers to study their size-dependent inhibitory effects against Bacillu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990642/ https://www.ncbi.nlm.nih.gov/pubmed/32010837 http://dx.doi.org/10.1021/acsomega.9b03698 |
_version_ | 1783492546933030912 |
---|---|
author | Cherukuri, Pavan Kumar Songkiatisak, Preeyaporn Ding, Feng Jault, Jean-Michel Xu, Xiao-Hong Nancy |
author_facet | Cherukuri, Pavan Kumar Songkiatisak, Preeyaporn Ding, Feng Jault, Jean-Michel Xu, Xiao-Hong Nancy |
author_sort | Cherukuri, Pavan Kumar |
collection | PubMed |
description | [Image: see text] Multidrug membrane transporters can extrude a wide range of substrates, which cause multidrug resistance and ineffective treatment of diseases. In this study, we used three different sized antibiotic drug nanocarriers to study their size-dependent inhibitory effects against Bacillus subtilis. We functionalized 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm silver nanoparticles (Ag NPs) with a monolayer of 11-amino-1-undecanethiol and covalently linked them with antibiotics (ofloxacin, Oflx). The labeling ratios of antibiotics with NPs are 8.6 × 10(2), 9.4 × 10(3), and 6.5 × 10(5) Oflx molecules per NP, respectively. We designed cell culture medium in which both BmrA and ΔBmrA cells grew and functioned normally while ensuring the stabilities of nanocarriers (nonaggregation). These approaches allow us to quantitatively study the dependence of their inhibitory effect against two isogenic strains of B. subtilis, WT (normal expression of BmrA) and ΔBmrA (deletion of bmrA), upon the NP size, antibiotic dose, and BmrA expression. Our results show that the inhibitory effects of nanocarriers highly depend on NP size and antibiotic dose. The same amount of Oflx on 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm nanocarriers shows the 3× lower, nearly the same, and 10× higher inhibitory effects than that of free Oflx, against both WT and ΔBmrA, respectively. Control experiments of the respective sized AgMUNH(2) NPs (absence of Oflx) show insignificant inhibitory effects toward both strains. Taken together, the results show multiple factors, such as labeling ratios, multivalent effects, and pharmacodynamics (Oflx localization and distribution), which might play the roles in the size-dependent inhibitory effects on the growth of both WT and ΔBmrA strains. Interestingly, the inhibitory effects of nanocarriers are independent of the expression of BmrA, which could be attributed to the higher efflux of nanocarriers by other membrane transporters in both strains. |
format | Online Article Text |
id | pubmed-6990642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-69906422020-01-31 Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis Cherukuri, Pavan Kumar Songkiatisak, Preeyaporn Ding, Feng Jault, Jean-Michel Xu, Xiao-Hong Nancy ACS Omega [Image: see text] Multidrug membrane transporters can extrude a wide range of substrates, which cause multidrug resistance and ineffective treatment of diseases. In this study, we used three different sized antibiotic drug nanocarriers to study their size-dependent inhibitory effects against Bacillus subtilis. We functionalized 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm silver nanoparticles (Ag NPs) with a monolayer of 11-amino-1-undecanethiol and covalently linked them with antibiotics (ofloxacin, Oflx). The labeling ratios of antibiotics with NPs are 8.6 × 10(2), 9.4 × 10(3), and 6.5 × 10(5) Oflx molecules per NP, respectively. We designed cell culture medium in which both BmrA and ΔBmrA cells grew and functioned normally while ensuring the stabilities of nanocarriers (nonaggregation). These approaches allow us to quantitatively study the dependence of their inhibitory effect against two isogenic strains of B. subtilis, WT (normal expression of BmrA) and ΔBmrA (deletion of bmrA), upon the NP size, antibiotic dose, and BmrA expression. Our results show that the inhibitory effects of nanocarriers highly depend on NP size and antibiotic dose. The same amount of Oflx on 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm nanocarriers shows the 3× lower, nearly the same, and 10× higher inhibitory effects than that of free Oflx, against both WT and ΔBmrA, respectively. Control experiments of the respective sized AgMUNH(2) NPs (absence of Oflx) show insignificant inhibitory effects toward both strains. Taken together, the results show multiple factors, such as labeling ratios, multivalent effects, and pharmacodynamics (Oflx localization and distribution), which might play the roles in the size-dependent inhibitory effects on the growth of both WT and ΔBmrA strains. Interestingly, the inhibitory effects of nanocarriers are independent of the expression of BmrA, which could be attributed to the higher efflux of nanocarriers by other membrane transporters in both strains. American Chemical Society 2020-01-13 /pmc/articles/PMC6990642/ /pubmed/32010837 http://dx.doi.org/10.1021/acsomega.9b03698 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Cherukuri, Pavan Kumar Songkiatisak, Preeyaporn Ding, Feng Jault, Jean-Michel Xu, Xiao-Hong Nancy Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis |
title | Antibiotic Drug Nanocarriers for Probing of Multidrug
ABC Membrane Transporter of Bacillus subtilis |
title_full | Antibiotic Drug Nanocarriers for Probing of Multidrug
ABC Membrane Transporter of Bacillus subtilis |
title_fullStr | Antibiotic Drug Nanocarriers for Probing of Multidrug
ABC Membrane Transporter of Bacillus subtilis |
title_full_unstemmed | Antibiotic Drug Nanocarriers for Probing of Multidrug
ABC Membrane Transporter of Bacillus subtilis |
title_short | Antibiotic Drug Nanocarriers for Probing of Multidrug
ABC Membrane Transporter of Bacillus subtilis |
title_sort | antibiotic drug nanocarriers for probing of multidrug
abc membrane transporter of bacillus subtilis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990642/ https://www.ncbi.nlm.nih.gov/pubmed/32010837 http://dx.doi.org/10.1021/acsomega.9b03698 |
work_keys_str_mv | AT cherukuripavankumar antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis AT songkiatisakpreeyaporn antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis AT dingfeng antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis AT jaultjeanmichel antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis AT xuxiaohongnancy antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis |